Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

  • RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    • News

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

  • AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    • News

  • Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    • News

  • Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    • News

  • FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    • News

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

Cronos all set to launch new version of app to sell cannabis

  • In News
  • September 23, 2022
  • Alinda Gupta
Cronos all set to launch new version of app to sell cannabis

Cannabis consumers rejoice, medicinal cannabis provider Cronos Australia (ASX:CAU) is very close to finally releasing its Canview platform to make the procurement of the drug an easy affair.

The roll-out is happening across stages with the first one comprising a number of order fulfilment upgrades, process improvements and other efficiencies. It was deployed internally within the Company in May this year. It has helped increase the speed and accuracy of order processing for the distribution team.

Cronos Australia CEO, Rodney Cocks, commented, “We are very pleased to be delivering such a wide range of important new features to our large and growing number of CanView users.”

“The network effect on the platform is clear which will drive further patient, prescriber and pharmacist onboarding. We are confident that the improved functionality of the CanView 2.0 platform will not only provide a superior user experience but help Cronos Australia to maintain its current market-leading position.” 

The Company launched its upgraded pharmacy ordering platform to the market in September, and over 3,000 pharmacy accounts on CanView have now successfully transitioned to the new software. Till now, the Company hasn’t received any major complaints about the new platform. 

On the new Canview app, users can receive prescriptions and TGA approvals directly from doctors/prescribers that are on the platform. This way, patients can order repeats directly from Canview 2.0. Cronos is also working on setting up a feature that will display real-time availability of products.

If all goes well with the rollout, the Company will offer pharmacies the option of one touch integration with CanView so that they can save time and deliver orders efficiently.

Cronos has also completed stage three of the program which will be introduced in early October. Currently, there are about 800 doctors on the platform, which is 3% of all general practitioners in the country. The Company is recruiting more medical practitioners on to the platform and plans on meeting with clinical groups and individual doctors to offer CanView as the “all in one” education, prescribing and compliance tool to be used in clinical settings. 

Through the app, doctors can generate electronic prescriptions, store TGA approval documents and view available stock levels during consultations with patients. Patients, on the other hand, will be able to receive prescriptions from CanView Prescribers and order repeats from the pharmacy through the mobile app. They can also track their orders and receive delivery notifications through the mobile app and through SMS.

While creating an online marketplace to sell marijuana might sound multiple kinds of whacky, it seems to be working well for Cronos as the platform cements its position as a reliable middleman between doctors and patients.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • asx cau
  • cannabis
  • canview
  • cau
  • cronos
  • cronos australia
  • rodney cocks
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.